Literature DB >> 22253358

Late positive remodeling and late lumen gain contribute to vascular restoration by a non-drug eluting bioresorbable scaffold: a four-year intravascular ultrasound study in normal porcine coronary arteries.

Erika Strandberg1, Joan Zeltinger, Daryl G Schulz, Greg L Kaluza.   

Abstract

BACKGROUND: The interplay between mechanical dilatation, resorption, and arterial response following implantation of bioresorbable scaffolds is still poorly understood. METHODS AND
RESULTS: Long-term geometric changes in porcine coronary arteries in relation to gradual degradation of bioresorbable scaffolds were assessed in comparison with bare metal stents (BMS). Intravascular ultrasound (IVUS)-derived lumen, outer stent/scaffold, and reference vessel areas were evaluated in 94 polymer scaffolds and 46 BMS at 5 days and 3, 6, 12, 18, 24, and 55 months, in addition to polymer scaffold radial crush strength and molecular weight (M(W)) at 3, 6, and 12 months. BMS outer stent area and lumen area remained constant through 55 months (P=0.05, but within 1 standard deviation of 100%, and P=0.58, respectively), while significant increases were exhibited by polymer-scaffolded vessels with the maximum late lumen gain at 24 months, paralleled by the outer scaffold area increase, and then remaining at that increased level at 55 months (P<0.01). By 12 months polymer scaffolds experienced significant reductions in radial strength and M(W), while the animals underwent the largest weight gain. At 3 months and beyond, the patency ratio (lumen area/reference vessel area) of BMS remained constant (0.71 to 0.85, P=0.49). In contrast, that of polymer scaffolds increased and approached 1 (P=0.13).
CONCLUSIONS: Bioresorbable polymer scaffolds allow restoration of the treated segment's ability to remodel outward to achieve level lumen transition between reference vessel and scaffold-treated regions, a process mediated by animal growth and scaffold degradation. This also introduces a challenge to standard analyses of IVUS outcomes relying on constant stent diameters over time.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22253358     DOI: 10.1161/CIRCINTERVENTIONS.111.964270

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  9 in total

1.  Two-year longitudinal evaluation of a second-generation thin-strut sirolimus-eluting bioresorbable coronary scaffold with hybrid cell design in porcine coronary arteries.

Authors:  Pawel Gasior; Yanping Cheng; Jinggang Xia; Gerard B Conditt; Jennifer C McGregor; Renu Virmani; Juan F Granada; Grzegorz L Kaluza
Journal:  Cardiol J       Date:  2018-08-29       Impact factor: 2.737

2.  Molecular design and evaluation of biodegradable polymers using a statistical approach.

Authors:  Dan Y Lewitus; Fabian Rios; Ramiro Rojas; Joachim Kohn
Journal:  J Mater Sci Mater Med       Date:  2013-07-26       Impact factor: 3.896

3.  Everolimus-Eluting Bioresorbable Vascular Scaffold in Real World Practice - A Single Center Experience.

Authors:  Huai-Wen Liang; Hsien-Li Kao; Yen-Hung Lin; Juey-Jen Hwang; Mao-Shin Lin; Fu-Tien Chiang; Chii-Ming Lee; Chih-Fan Yeh; Tzung-Dau Wang; Cho-Kai Wu; Lian-Yu Lin; Chia-Ti Tsai; Ying-Hsien Chen
Journal:  Acta Cardiol Sin       Date:  2017-05       Impact factor: 2.672

4.  Bioresorbable Vascular Scaffolds in Interventional Neuroradiology.

Authors:  Anil Arat; Ergun Daglioglu; Ilkay Akmangit; Ahmet Peker; Murat Arsava; Mehmet Akif Topcuoglu; Deniz Belen
Journal:  Clin Neuroradiol       Date:  2017-07-26       Impact factor: 3.649

Review 5.  Bioresorbable scaffolds: current evidence and ongoing clinical trials.

Authors:  Christos V Bourantas; Yaojun Zhang; Vasim Farooq; Hector M Garcia-Garcia; Yoshinobu Onuma; Patrick W Serruys
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

6.  Echogenicity as a surrogate for bioresorbable everolimus-eluting scaffold degradation: analysis at 1-, 3-, 6-, 12- 18, 24-, 30-, 36- and 42-month follow-up in a porcine model.

Authors:  Carlos M Campos; Yuki Ishibashi; Jeroen Eggermont; Shimpei Nakatani; Yun Kyeong Cho; Jouke Dijkstra; Johan H C Reiber; Alexander Sheehy; Jennifer Lane; Marika Kamberi; Richard Rapoza; Laura Perkins; Hector M Garcia-Garcia; Yoshinobu Onuma; Patrick W Serruys
Journal:  Int J Cardiovasc Imaging       Date:  2015-01-28       Impact factor: 2.357

7.  Bioresorbable scaffolds in the treatment of coronary artery disease.

Authors:  Yaojun Zhang; Christos V Bourantas; Vasim Farooq; Takashi Muramatsu; Roberto Diletti; Yoshinobu Onuma; Hector M Garcia-Garcia; Patrick W Serruys
Journal:  Med Devices (Auckl)       Date:  2013-03-12

Review 8.  Vascular restoration therapy and bioresorbable vascular scaffold.

Authors:  Yunbing Wang; Xingdong Zhang
Journal:  Regen Biomater       Date:  2014-10-20

9.  Multimodality intravascular imaging of bioresorbable vascular scaffolds implanted in vein grafts.

Authors:  Tomasz Roleder; Elzbieta Pociask; Wojciech Wanha; Pawel Gasior; Magdalena Dobrolinska; Magdalena Garncarek; Przemyslaw Pietraszewski; Radoslaw Kurzelowski; Grzegorz Smolka; Wojciech Wojakowski
Journal:  Postepy Kardiol Interwencyjnej       Date:  2019-06-26       Impact factor: 1.426

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.